NEW YORK (GenomeWeb News) – The stem cell-based pharmaceutical company ImmuneRegen will use HemoGenix’ cell-based assay technology in its studies of a therapeutic candidate designed as a response to bioterrorism threats, ImmuneRegen said today.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Berkeley researchers have engineered yeast to make the molecule behind the hoppy taste of beer, Quartz reports.

King's College London researchers examine the influence of school type and genetics on academic achievement.

FiveThirtyEight writes that most who take a direct-to-consumer BRCA1/2 genetic test won't learn much from it.

In Science this week: early life experience influence somatic variation in the genome, and more.